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Preference-Adaptive Randomization in Comparative Effectiveness Studies
Abstract
Background
Determination of comparative effectiveness in a randomized controlled trial requires consideration of an
intervention’s comparative uptake (or acceptance) among randomized participants and the intervention’s
comparative efficacy among participants who use their assigned intervention. If acceptance differs
across interventions, then simple randomization of participants can result in post-randomization losses
that introduce bias and limit statistical power.
Methods
We develop a novel preference-adaptive randomization procedure in which the allocation probabilities are
updated based on the inverse of the relative acceptance rates among randomized participants in each
arm. In simulation studies, we determine the optimal frequency with which to update the allocation
probabilities based on the number of participants randomized. We illustrate the development and
application of preference-adaptive randomization using a randomized controlled trial comparing the
effectiveness of different financial incentive structures on prolonged smoking cessation.
Results
Simulation studies indicated that preference-adaptive randomization performed best with frequent
updating, accommodated differences in acceptance across arms, and performed well even if the initial
values for the allocation probabilities were not equal to their true values. Updating the allocation
probabilities after randomizing each participant minimized imbalances in the number of accepting
participants across arms over time. In the smoking cessation trial, unexpectedly large differences in
acceptance among arms required us to limit the allocation of participants to less acceptable
interventions. Nonetheless, the procedure achieved equal numbers of accepting participants in the more
acceptable arms, and balanced the characteristics of participants across assigned interventions.
Conclusions
Preference-adaptive randomization, coupled with analysis methods based on instrumental variables, can
enhance the validity and generalizability of comparative effectiveness studies. In particular, preferenceadaptive randomization augments statistical power by maintaining balanced sample sizes in efficacy
analyses, while retaining the ability of randomization to balance covariates across arms in effectiveness
analyses.
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Abstract
Background: Determination of comparative effectiveness in a randomized controlled trial requires consideration of
an intervention’s comparative uptake (or acceptance) among randomized participants and the intervention’s
comparative efficacy among participants who use their assigned intervention. If acceptance differs across
interventions, then simple randomization of participants can result in post-randomization losses that introduce bias
and limit statistical power.
Methods: We develop a novel preference-adaptive randomization procedure in which the allocation probabilities
are updated based on the inverse of the relative acceptance rates among randomized participants in each arm. In
simulation studies, we determine the optimal frequency with which to update the allocation probabilities based on
the number of participants randomized. We illustrate the development and application of preference-adaptive
randomization using a randomized controlled trial comparing the effectiveness of different financial incentive
structures on prolonged smoking cessation.
Results: Simulation studies indicated that preference-adaptive randomization performed best with frequent
updating, accommodated differences in acceptance across arms, and performed well even if the initial values for the
allocation probabilities were not equal to their true values. Updating the allocation probabilities after randomizing
each participant minimized imbalances in the number of accepting participants across arms over time. In the smoking
cessation trial, unexpectedly large differences in acceptance among arms required us to limit the allocation of
participants to less acceptable interventions. Nonetheless, the procedure achieved equal numbers of accepting
participants in the more acceptable arms, and balanced the characteristics of participants across assigned
interventions.
Conclusions: Preference-adaptive randomization, coupled with analysis methods based on instrumental variables,
can enhance the validity and generalizability of comparative effectiveness studies. In particular, preference-adaptive
randomization augments statistical power by maintaining balanced sample sizes in efficacy analyses, while retaining
the ability of randomization to balance covariates across arms in effectiveness analyses.
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Background
Health-care providers, employers and insurers want to
promote healthy behaviors, including medication adherence, tobacco cessation, weight loss and exercise [1-5].
The comparative effectiveness of any behavioral intervention depends on both its comparative acceptance (i.e., the
probability that people assigned to an intervention will
use it) and its comparative efficacy (i.e., how well the
intervention works among people who use it) [6,7]:


Effectiveness : = Efficacy | Acceptance ×Acceptance.
(1)
Therefore, it is essential to disentangle acceptance and
efficacy to determine whether an intervention’s effectiveness is limited by low acceptance or low efficacy
[8]. Unfortunately, disentangling acceptance and efficacy
within randomized controlled trials is challenging. Simple
randomization (or complete randomization) of participants to different interventions ensures that measures of
effectiveness are not confounded by differences in the
characteristics of individuals to whom the interventions
are offered [9]. However, random assignment to interventions that yield different levels of acceptance can induce
post-randomization losses that introduce bias and limit
statistical power in standard analyses of the interventions’
comparative efficacy [10].
We recently designed a randomized controlled trial to
compare the effectiveness of different financial incentive
structures on prolonged smoking cessation (clinicaltrials.gov identifier: NCT01526265). Some of the financial
incentive structures required participants to put some of
their own money at risk, which might naturally be less
attractive to participants than incentives with only upside
potential. To promote the goals of achieving equal numbers of accepting participants in each arm and balancing
the characteristics of participants across assigned interventions, we adapted the allocation probabilities throughout the enrollment period based on the inverse of the
relative acceptance rates among randomized participants
in each arm. Thus, our approach increased the likelihood
that a participant was randomized to an intervention that
had been rejected by previously randomized participants.
Our preference-adaptive randomization procedure was
intended to augment the statistical power of an instrumental variable analysis of efficacy [11], while reducing
the potential for participant characteristics to bias an
intention-to-treat analysis of effectiveness.
A large body of statistical literature has focused on
adaptive designs for randomized trials. Brown and colleagues [12] conceptualized three types of adaptation:
adaptive sequencing, which refers to the design of a new
trial; adaptive designs, which refers to the conduct of
an ongoing trial; and adaptive interventions, which refer

to intervention experience of a study participant. Adaptive designs include covariate-adaptive randomization, in
which allocation probabilities vary to minimize covariate
imbalances across arms, and response-adaptive randomization, which uses the success or failure results on previously randomized participants in each arm to modify the
allocation probabilities [13-15]. For example, in a randomized play-the-winner design, a participant is more likely
to be randomized to an intervention deemed more successful based on the outcomes observed for previously
randomized participants [16,17].
Our preference-adaptive randomization procedure
shares elements of covariate- and response-adaptive
randomization [18], but is distinct from each. On one
hand, our randomization procedure could be viewed as
response-adaptive. The acceptance analysis compares
the relative proportions of participants who accept their
assigned intervention. Acceptance among previously
randomized participants is the response upon which
the allocation probabilities are updated. On the other
hand, our procedure could be viewed as a unique case of
covariate-adaptive randomization. The efficacy analysis
compares the relative rates of sustained smoking cessation among those who accept their assigned intervention.
In the efficacy analysis, acceptance is conditioned as a
special type of covariate. The special role of acceptance as
both an effect and a cause in a comparative effectiveness
study is similar to the role of the amount of treatment
taken in a randomized encouragement design [19,20].
In this paper, we introduce a novel adaptive randomization procedure in which the allocation probabilities are
updated based on the relative acceptance rates among
randomized participants. Our goal is to elucidate the statistical and practical properties of adaptive randomization
procedures, using comparative effectiveness studies as a
motivating framework. In simulation studies, we determine the optimal frequency with which to update the allocation probabilities based on the number of participants
randomized. We illustrate the development and application of our preference-adaptive randomization procedure,
and demonstrate the benefits and challenges of an adaptive design, using the smoking cessation trial introduced
above. We discuss instrumental variable methods that can
be used to analyze the resultant efficacy data.

Methods
We develop an adaptive randomization procedure in
which the allocation probabilities are updated based on
the inverse of the relative acceptance rates among randomized participants in each arm. In this approach, a
participant is more likely to be randomized to an intervention that was deemed less acceptable among previously
randomized participants. We accommodate stratified randomization by updating the allocation probabilities within
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each stratum, with the constraint that the sum of the
probabilities within each stratum is 1.
Let πijk denote the allocation probability for arm (or
intervention) j = 1, . . . , J within stratum i = 1, . . . , I
at update k = 1, . . . , Ki . The total number of updates
Ki could vary across strata due to differences in sample
sizes. Let nijk denote the number of participants in stratum i who have
 accepted intervention j up to update k,
with ni·k =
j nijk . The allocation probability for arm j
within stratum i at update k can be calculated based on
the accrued relative acceptance rates:
πijk

ni·k
1
= πijk−1 ×
×
,
nijk
si·k

1
1
×
.
nijk
j πij k−1 /nij k

We designed the simulation studies to emulate our smoking cessation trial: a five-arm trial with a target sample size
of 2,185 accepting participants. For simplicity, we did not
assume stratified randomization. We considered updating
intervals of 1, 3, 5, 10 and 20 participants. For example,
with an updating interval of 3 participants, the allocation
probabilities were updated after 3 participants were randomized since the last update. We defined the efficiency
of an updating interval based on the sum of the squared
deviations from an allocation probability of 0.2:
⎤−1
N 
5 

2
(l)
pjn − 0.2 ⎦ ,
e(l) = ⎣
⎡

(2)


for which si·k = ni·k 
× j πij k−1 /nij k denotes a scaling
factor to ensure that j πijk = 1. Note that Equation (2)
reduces to:
πijk = πijk−1 ×

Parameters

(3)

Anticipated acceptance rates can be used to select the
initial allocation probabilities πij0 , allowing for anticipated
differences in acceptance within and across strata. In our
smoking cessation trial, we assumed that the initial probabilities were constant across strata, but varied across arms
within a stratum: π1j0 = π2j0 = · · · = πIj0 ∀ j.
To implement our procedure, one must choose the frequency with which to update the allocation probabilities.
Less frequent updating might not be responsive to differential acceptance rates across the interventions. More
frequent updating might overcompensate for chance
imbalances. Furthermore, it could require real-time data
collection and analysis, which might not be feasible. In
the following section, we use simulated data to determine
the optimal frequency with which to update the allocation
probabilities.

Simulation studies
We performed simulation studies to determine the
optimal frequency with which to update the allocation
probabilities based on the number of participants randomized. The goal was to identify the updating interval
that minimized imbalances in the numbers of accepting participants across arms over time. We hypothesized
that insufficiently frequent updating would enable certain arms to grow disproportionately before change was
enforced. Conversely, we hypothesized that overly frequent updating would be inefficient because, particularly
early in the study, the procedure would overreact to
variable acceptance rates, for which the denominators
represented small samples of participants.

(4)

n=n0 j=1

for which p(l)
jn denotes the proportion of participants who
have accepted intervention j among all participants who
have accepted their assigned intervention at the time at
which a total of n = n0 , . . . , N participants have accepted
their assigned intervention, under a randomization procedure with an updating interval of l participants. We
selected n0 = 100 as a burn-in time, so that the efficiency was not influenced by early time periods during
which the proportions in each arm were unstable. We
selected N = 2,185 as the total number of participants who
accept their assigned intervention. The efficiency measure in Equation (4) quantified the average imbalance in
acceptance across arms over time, and is analogous to the
efficiency measure proposed by Chen [21] for assessing
sequential randomization schemes designed to balance
the number of participants across arms. We defined the
relative efficiency as the efficiency of an updating interval of l participants relative to that of an updating interval
of 20 participants, i.e., e(l)/e(20), l = 1, 3, 5, 10. A relative
efficiency >1 indicated increased efficiency.
We compared the efficiency of different updating intervals across a range of scenarios, in which we varied three
primary factors:
1. Acceptance probability for the most accepted
intervention : The true acceptance probability for the
arm with the largest acceptance probability was 0.2,
0.4, 0.5, 0.6 or 0.8.
2. Acceptance probabilities for less accepted
interventions : The acceptance probabilities for the
arms other than the arm with the largest acceptance
probability were divided evenly or unevenly. If
divided evenly, then they were all set to 0.5 times the
acceptance probability for the arm with the largest
acceptance probability. If divided unevenly, then they
were set to 0.2, 0.4, 0.6 and 0.8 times the acceptance
probability for the arm with the largest acceptance
probability.
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3. Initial values for acceptance probabilities : The initial
values for the acceptance probabilities:
(a) Correct : Were equal to the true acceptance
probabilities.
(b) More extreme : Were unequal to the true
acceptance probabilities, with the initial value
for the arm with the largest acceptance
probability set to 1.2 times its true value and
the remaining initial values set to 0.8 times
their true values.
(c) Less extreme : Were unequal to the true
acceptance probabilities, with the initial value
for the arm with the largest acceptance
probability set to 0.8 times its true value and
the remaining initial values set to 1.2 times
their true values.
The initial allocation probabilities were proportional
to the inverse of the initial acceptance probabilities.
We performed 500 iterations for each of the 30 scenarios in the full 5 × 2 × 3 factorial design. Both overall and
for each of the three primary factors, we summarized the
results by calculating an average relative efficiency (ARE);
for each scenario, we calculated the ARE for that scenario
and then averaged the AREs across scenarios. Simulations
were performed using R 3.1.0 (R Development Core Team,
Vienna, Austria), including the e1071 extension package.
Results

Across all 30 scenarios in the full 5 × 2 × 3 factorial design,
the average ARE for an updating interval of 1, 3, 5 and 10
participants (compared to an updating interval of 20 participants) was 1.21, 1.11, 1.08 and 1.03, respectively, which
indicated that, on average, more frequent updating led to
increased efficiency. On average, an updating interval of
1 participant was 21% more efficient than an updating
interval of 20 participants. Table 1 provides the average
ARE according to the acceptance probability for the most
accepted intervention. Note that a lower acceptance probability for the most accepted intervention corresponded

Table 1 Average efficiency relative to an updating interval
of 20 participants according to the acceptance probability
for the most accepted intervention
Updating interval

Acceptance probability for
most accepted intervention

to lower acceptance probabilities among all interventions.
The efficiency gain of more frequent updating was lower
for lower values of the acceptance probabilities. If acceptance was lower, then more frequent updating was more
sensitive to individual responses and therefore led to
larger imbalances in the number of accepting participants
across arms over time.
Table 2 provides the average ARE according to the
distribution of the acceptance probabilities for the less
accepted interventions. The efficiency gain of more frequent updating was higher for an uneven distribution,
which indicated that more frequent updating was more
efficient when there were more substantial differences
among acceptance probabilities. Table 3 provides the average ARE according to the initial values for the acceptance
probabilities. There were no substantial differences in the
average ARE when the initial values were correct or incorrect, which indicated that the randomization procedure
recovered from incorrect initial values.
Results were similar (within 1% to 2%) when no burn-in
time was used to calculate the efficiencies.
Summary

Our preference-adaptive randomization procedure –
based on the inverse of the relative acceptance rates
among randomized participants in each arm – performed
best with frequent updating, accommodated differences
in acceptance across interventions, and was robust to
incorrect initial values. An updating interval of 1 participant performed well across all scenarios considered.

Illustration
Background

We designed a randomized controlled trial of smoking
cessation interventions among CVS/Caremark employees
and their friends and family members. The goal of the
study was to compare usual care (e.g., access to online
information on smoking cessation, access to phone-based

Table 2 Average efficiency relative to an updating interval
of 20 participants according to the distribution of the
acceptance probabilities for the less accepted
interventions
Updating interval

Acceptance probabilities for
less accepted interventions
Even

Uneven

1

1.16

1.26

0.2

0.4

0.5

0.6

0.8

3

1.08

1.15

1

1.14

1.19

1.21

1.26

1.28

5

1.05

1.11

3

1.09

1.10

1.11

1.12

1.12

10

1.02

1.05

5

1.05

1.06

1.06

1.08

1.08

10

1.02

1.02

1.03

1.03

1.02

Even: All set to 0.5 times the acceptance probability for the arm with the largest
acceptance probability. Uneven: Set to 0.2, 0.4, 0.6 and 0.8 times the acceptance
probability for the arm with the largest acceptance probability.
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Table 3 Average efficiency relative to an updating interval
of 20 participants according to the initial values for the
acceptance probabilities
Updating interval

Initial values for acceptance probabilities
Correct

More extreme

Less extreme

1

1.20

1.20

1.21

3

1.11

1.11

1.11

5

1.09

1.07

1.08

10

1.03

1.04

1.03

Correct: Equal to the true acceptance probabilities. More extreme: Unequal to
the true acceptance probabilities, with the initial value for the arm with the
largest acceptance probability set to 1.2 times its true value and the remaining
initial values set to 0.8 times their true values. Less extreme: Unequal to the true
acceptance probabilities, with the initial value for the arm with the largest
acceptance probability set to 0.8 times its true value and the remaining initial
values set to 1.2 times their true values.

cessation assistance and nicotine replacement therapy)
with usual care plus one of four financial incentive structures likely to vary in their appeal to participants. Participants in the individual reward arm received a financial
reward if they achieved sustained abstinence. In the collaborative reward arm, a participant was assigned to a
group of six participants; a participant’s financial reward
for sustained abstinence was increased as the abstinence
rate among group members increased. Participants in the
individual deposit arm deposited money at the beginning
of the study; if they achieved sustained abstinence, then
they received their deposit plus a financial reward. In the
competitive deposit arm, a participant was assigned to
a group of six participants; deposits were redistributed
among only those group members who achieved sustained
abstinence.
Methods

The target sample size was 2,185 smokers (437 per arm)
who would accept their assigned intervention. Over a
9-month enrollment period, potential participants were
recruited via a web-based research portal [22]. Participants were told that the smoking cessation interventions
involved the use of financial incentives, but specific details
of the interventions were not provided. Once randomized, participants received a detailed description of their
assigned intervention. We defined the acceptance rate
as the proportion of participants randomized to each of
the four incentive arms who, after learning the details
of the incentive structure to which they were assigned,
agreed to the contract. In the usual care arm, acceptance
was assumed for everyone because no new intervention
was offered. Participants who accepted the collaborative
reward or competitive deposit intervention were subsequently assigned to a group of six participants. Because
group assignment occurred after acceptance, it was not
necessary to adjust for group effects when calculating

acceptance rates. All participants provided informed consent. The University of Pennsylvania Institutional Review
Board approved the study protocol.
We stratified the randomization by two dichotomous
variables: whether or not participants had full healthcare benefits through CVS/Caremark; and annual household income above or below $60,000. Initial allocation
probabilities across strata were: usual care, 0.20; individual reward, 0.15; collaborative reward, 0.15; individual
deposit, 0.25; and competitive deposit, 0.25. This unbalanced randomization was intended to account for hypothesized differences in acceptance rates across arms; in
particular, we predicted that participants would be less
likely to accept deposit contracts because those require
participants to put up some of their own money at the
start, and risk not getting it back if they do not succeed in
quitting. To further promote the goals of achieving equal
numbers of accepting participants in each arm and balancing the characteristics of participants across assigned
interventions, we also adapted the allocation probabilities within strata throughout the enrollment period.
Although our simulation studies indicated that an updating interval of 1 participant performed well, we used an
updating interval of 3 participants to reduce the complexity of the required programming in the web-based
portal.
Results

The preference-adaptive randomization procedure we
implemented resulted in marked variations in the proportions of participants allocated to the different study arms
over time (Figure 1). For example, in the most populous
of the four strata (i.e., participants with annual household
incomes less than $60,000 who also lacked CVS/Caremark
benefits, or low income, no benefits), the percentage of
participants allocated to the individual deposit arm varied
from <5% to >80% during the initial enrollment period.
During this same time, allocation probabilities for each of
the arms exceeded 50% at one or more points in time, and
each dropped to <15% at other times.
Following the first 7 weeks of recruitment, with nearly
1,000 participants enrolled, we recognized that the interventions had differences in acceptance rates much larger
than we originally hypothesized. We concluded that if we
did not modify the randomization procedure, so many
participants would be diverted to the least acceptable
interventions that we would fail to adequately enroll any of
the arms because of limitations on eligible participants. To
combat this problem, we implemented a series of restrictions on the allocation probabilities. We set ceilings for
the proportion of participants allocated to the least popular arms (i.e., individual deposit and competitive deposit).
After this initial change 7 weeks into the study (denoted
by A in Figure 1), we made subsequent modifications 9,
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Arm

Usual care
A

Collaborative reward

Individual deposit

Competitive deposit

B

C

D

0.8
0.6
0.4
0.2
0.0
1.0

B

C

D

Low income, benefits

A

0.8

0.4
0.2

A

B

C

High income, no benefits

Allocation probability

0.6

0.0
1.0

D

0.8
0.6
0.4
0.2
0.0
1.0

B

C

D

High income, benefits

A

Low income, no benefits

1.0

Individual reward

0.8
0.6
0.4
0.2
0.0
0

50

100

150

200

250

300

350

400

450

500

550

600

650

700

750

800

850

900

950

1000

Number randomized

Figure 1 Probability of being allocated to each incentive structure in each of the four strata over the enrollment period. A, B, C, and D
indicate protocol changes in the randomization procedure. These changes were made to address observed disparities in acceptance rates. On 11
April 2012, we implemented a 60%/40% split between [usual care + individual reward + collaborative reward arms] and [individual deposit +
competitive deposit arms] (A). On 25 April 2012, we changed to an 80%/20% split between the same two groups (B). On 14 September 2012, we
changed to a 50%/50% split between the same two groups (C). On 26 September 2012, we retained this 50%/50% split, continued the adaptive
randomization for the deposit arms, but among the 50% of participants randomized to the group containing the other three arms, we fixed the
allocation probabilities for the usual care (15%), individual reward (15%) and collaborative reward (70%) arms to bolster assignment to the latter (D).

29 and 31 weeks into the study (denoted by B, C and D,
respectively, in Figure 1).
Our preference-adaptive randomization procedure produced balance in the numbers of accepting participants in
the three arms that were reasonably well accepted by participants (i.e., usual care, individual reward and collaborative reward). Specifically, we achieved the target sample
size of at least 437 participants in each of those arms, with
negligible differences in the numbers of accepting participants among those arms. The procedure also successfully balanced the characteristics of participants across
assigned interventions. Indeed, of the more than 30 participant characteristics that we measured, none revealed
an important imbalance across arms. Only one variable,
ethnicity, was statistically unbalanced (P = 0.042).
Balance across arms was not uniformly achieved
when evaluating only participants who accepted their
assigned intervention (Table 4). In particular, annual
household income was highly imbalanced, with an

over-representation of high-income individuals in the
individual deposit and competitive deposit arms (P < 0.001).
These results provide support for the concern that analyses based on participants who accepted their assigned
intervention would be susceptible to selection effects. In
the following section, we discuss instrumental variable
methods that can address such selection effects.
Summary

We designed a randomized controlled trial to compare
the effectiveness of different financial incentive structures on prolonged smoking cessation. We implemented
a preference-adaptive randomization procedure in which
allocation probabilities within strata were updated after
every third participant based on the relative acceptance rates among randomized participants. The procedure required direct modification during the enrollment
period, but nevertheless achieved its stated goals. First, for
the three arms we targeted for complete enrollment, we
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Table 4 Participant characteristics by accepted intervention
Usual
care
n = 468

Individual
reward
n = 472

Collaborative
reward
n = 442

Individual
deposit
n = 75

Competitive
deposit
n = 71

P

Age, years

34 (26, 47)

33 (25, 46)

32 (25, 45)

41 (27, 51)

34 (26, 43)

0.032

Female sex, n (%)

300 (64)

301 (64)

278 (63)

38 (51)

42 (59)

0.23

365 (78)

389 (82)

328 (74)

62 (83)

60 (85)

Race, n (%)
Caucasian

0.090

African American

43 (9)

42 (9)

55 (12)

5 (7)

4 (6)

Other

60 (13)

41 (9)

59 (13)

8 (11)

7 (10)

42 (9)

30 (6)

23 (5)

4 (5)

4 (6)

Hispanic ethnicity, n (%)

0.21
<0.001

Annual household income, n (%)
<$20,000

114 (24)

111 (24)

117 (26)

10 (13)

8 (11)

$20,000 to $39,999

143 (31)

154 (33)

139 (31)

16 (21)

16 (23)

$40,000 to $59,999

89 (19)

93 (20)

71 (16)

11 (15)

13 (18)

$60,000 to $79,999

59 (13)

49 (10)

41 (9)

13 (17)

11 (15)

$80,000 to $99,999

28 (6)

25 (5)

34 (8)

8 (11)

6 (8)

≥$100,000

35 (7)

40 (8)

40 (9)

17 (23)

17 (24)

CVS/Caremark benefits, n (%)

188 (40)

199 (42)

176 (40)

41 (55)

37 (51)

0.051

Years as a regular smoker

15 (6, 26)

12 (6, 25)

13 (6, 25)

17 (6, 30)

15 (7, 24)

0.49

Cigarettes smoked per day

15 (10, 20)

15 (10, 20)

15 (9, 20)

15 (10, 20)

15 (10, 20)

0.62

Summary statistics are median (25th, 75th percentile) unless otherwise noted as n (%).

achieved equal numbers of accepting participants in each
arm, which will enhance the power of the efficacy analyses. Second, we achieved balance in the characteristics
of participants across assigned interventions, which will
reduce the potential for bias in the effectiveness analysis.

Estimation of treatment effects
In previous sections, we described the development and
implementation of a preference-adaptive randomization
procedure in comparative effectiveness studies, using a
smoking cessation trial as an illustrative example. In this
section, we outline an analysis plan to estimate acceptance, efficacy and effectiveness; see Equation (1).
A standard intention-to-treat analysis is used to compare the treatments’ acceptance and effectiveness. For
evaluating efficacy, a standard per-protocol analysis would
compare the cessation rate among participants who accept
intervention j to those who receive the control (with or
without inclusion of those who were assigned intervention j but declined it). However, the standard per-protocol
analysis could be subject to selection bias if smokers
who do not accept an incentive differ from those who
do in ways that relate to their probabilities of quitting
[23]. To address such selection effects, we model the randomization arm as an instrumental variable [11]. In the
instrumental variable approach, the cessation rate of each
intervention is adjusted for the percentage of participants

who accept their assigned intervention, thereby estimating complier-averaged causal effects and attenuating the
selection effects [24,25].
A key advantage of the instrumental variable approach
over a standard per-protocol analysis is that the instrumental variable approach uses the data on all randomized participants, rather than merely those who accept
their assigned intervention. Therefore, the instrumental
variable approach adheres to the randomized trial principle that participants should be analyzed according to
their randomization status, rather than according to their
self-selected acceptance status. For the instrumental variable analysis, we will use a two-stage least squares linear
probability model [26]. By using the preference-adaptive
randomization procedure, which balances the number of
accepting participants in each arm (or, in our application,
the arms targeted for complete enrollment), we increase
the power for the instrumental variable analysis.

Discussion
In this paper, we introduced a preference-adaptive randomization procedure in which the allocation probabilities were updated based on the inverse of the relative
acceptance rates among randomized participants in each
arm. We showed that the procedure performed best with
frequent updating, accommodated differences in acceptance across interventions, and was robust to incorrect
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initial values. We applied our procedure to a randomized
controlled trial to compare the effectiveness of different
financial incentive structures on prolonged smoking cessation. The randomization procedure strengthened the
trial in at least three ways. First, the procedure highlighted the very low acceptance rates in certain arms
because it resulted in correspondingly high allocation
probabilities to those less acceptable arms. This enabled
us to modify the randomization procedure during enrollment to preserve the possibility of fully enrolling more
acceptable arms. Second, despite producing large variations in the allocation probabilities within and across
arms over time, the procedure yielded comparable numbers of accepting participants across the three arms that
we allowed to enroll appreciable numbers of participants,
as well as across the two arms in which allocation was
restricted when they were found to be less acceptable.
This across-arm balance will maximize statistical power.
Third, the procedure achieved balance in the observed
characteristics of participants across assigned interventions, which increases confidence that unmeasured characteristics (e.g., motivation to quit) would also be balanced
in the effectiveness analysis. Balance across arms was
not uniformly achieved when evaluating only participants
who accepted their assigned intervention, which provides
support for the concern that such analyses would be susceptible to selection effects. We discussed instrumental
variable methods that can address such selection effects.
Although our preference-adaptive randomization procedure performed well in simulation studies and in our
application, there are limitations to the procedure’s application. First, our simulation studies indicated that an
updating interval of 1 participant was optimal. In practice, however, such frequent updating could require a
sophisticated data-transmission and storage infrastructure to perform rapid data collection and analysis. In
our smoking cessation trial, we programmed the procedure into a web-based portal that was used for data
collection and randomization. Second, in our application the procedure required manual modification due
to lower-than-anticipated acceptance of less appealing
arms, and correspondingly higher-than-anticipated automatic adjustments to the allocation probabilities for those
arms. Left unchecked, those automatic adjustments would
have hampered our ability to adequately enroll any of the
arms. Future investigators might wish to program automatic modifications in their preference-adaptive randomization procedure, similar to the modifications that we
made manually (e.g., ceilings for the allocation probabilities). Third, our procedure could introduce confounding
because allocation probabilities might depend on a complicated function of time (within strata). If the response
also varies over time, then differences in the average
response between arms could be confounded by temporal
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trends. Therefore, when using this approach in practice,
it might be prudent to adjust for temporal trends (within
strata) using a flexible specification for calendar time, such
as regression splines. Fourth, like many adaptive designs
or interim analyses, preference-adaptive randomization
might require that a member of the study team, such as
a statistician, be unblinded during the trial. Unblinding
requires careful consideration of the statistician’s role in
the study’s conduct and reporting.
Our adaptive design, coupled with appropriate statistical analysis methods, could be used to enhance the validity and generalizability of any comparative effectiveness
study, blinded or unblinded, in which study participants
choose to adhere to their assigned intervention [9,27].
Examples include large simple trials of vaccines or virtually any pharmaceutical for which adherence might not be
100%, and, of course, trials of almost any behavioral intervention. However, application of our procedure requires
consideration of two key features of adherence: the time
lag between randomization and measurement of adherence; and whether adherence is assessed as a dichotomous
variable, or as an adherence proportion or rate. In our
smoking cessation trial, acceptance was measured immediately after randomization as being present or absent. By
contrast, in drug trials, adherence might not be measured
until several weeks or months after randomization, and
might be measured as a proportion of pills taken among
those prescribed.
Future research is needed to determine how a time lag
in the assessment of adherence influences the efficiency
of preference-adaptive randomization and the optimal
updating interval. Conceivably, with more distant measurements of adherence, more frequent updating would
be even more advantageous so that allocation probabilities can be modified as soon as adherence data become
available. Research is also needed to determine how best
to handle situations in which adherence is measured
as a proportion. The easiest, but perhaps least precise,
approach would be to set an adherence threshold, thereby
converting adherence to a dichotomous variable. However, more complex approaches, in which progressively
large differences in observed adherence rates result in
progressively large feedback influences on the allocation
probabilities, could also be developed. The potential applicability of such strategies is quite broad, but requires further testing to ensure that balance would still be achieved
across randomized arms.

Conclusions
In comparative effectiveness studies, frequent updating of
allocation probabilities – based on the inverse of the relative acceptance rates among randomized participants in
each arm – augments statistical power by maintaining balanced sample sizes in efficacy analyses, while retaining the
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ability of randomization to balance covariates across arms
in effectiveness analyses. Preference-adaptive randomization, coupled with statistical analysis methods based on
instrumental variables, could be used to enhance the
validity and generalizability of any comparative effectiveness study in which study participants choose to adhere to
their assigned intervention.
Abbreviation
ARE: Average relative efficiency.
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